Literature DB >> 30113762

Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment.

Annica Almståhl1, Jessica Skoogh Andersson2, Torgny Alstad3, Bodil Fagerberg-Mohlin4, Caterina Finizia5.   

Abstract

OBJECTIVE: The aim of this study was to analyse quality of life (QoL) pretreatment and up to 24 months post radiation therapy (RT) in patients with head and neck (H&N) cancer.
METHODS: Twenty-nine patients (19 men and 10 women) with a mean age of 59 ± 8 years were included. The stimulated salivary secretion was measured and the patients completed the European Organisation for Research and Treatment of Cancer Quality of Life questionnaires (EORTC QLQ-C30 and H&N35) and the Hospital Anxiety and Depression scale (HADS) pretreatment and at 6, 12 and 24 months post RT.
RESULTS: At all time-points after RT (6, 12, and 24 months), patients with hyposalivation (stimulated secretion rate ≤0.7 mL/min) reported clinically significant differences (> 10 points) regarding insomnia, swallowing, social eating, dry mouth, and sticky saliva. Statistically significant differences were found for emotional functioning and insomnia at 12 months (P < 0.05 for both) and for sticky saliva at both 12 and 24 months (P < 0.05 and P < 0.01). The number of clinically significant differences increased from 10 at both 6 and 12 months post-RT to 14 functioning/symptom scales and single items at the 24 months follow-up. At 24 months post RT, 21% of patients with hyposalivation had HADS scores suggesting anxiety problems compared to 7% for those with stimulated salivary secretion rates >0.7 mL/min.
CONCLUSION: Patients with hyposalivation showed deterioration in health related quality of life (QoL) at 24 months compared with 12 months post RT. Most pronounced were problems with insomnia, swallowing, social eating, dry mouth, and sticky saliva.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  head and neck cancer; hyposalivation; quality of life; radiation therapy; salivary secretion rate

Mesh:

Year:  2018        PMID: 30113762     DOI: 10.1111/idh.12363

Source DB:  PubMed          Journal:  Int J Dent Hyg        ISSN: 1601-5029            Impact factor:   2.477


  7 in total

1.  Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer.

Authors:  Laura Izabel Lampert Bonzanini; Eloisa Barbieri Soldera; Gabriela Barbieri Ortigara; Riéli Elis Schulz; Raquel Pippi Antoniazzi; Thiago Machado Ardenghi; Kívia Linhares Ferrazzo
Journal:  Support Care Cancer       Date:  2019-08-02       Impact factor: 3.603

2.  Trimers Conjugated to Fibrin Hydrogels Promote Salivary Gland Function.

Authors:  H T Dos Santos; K Nam; C T Brown; S M Dean; S Lewis; C S Pfeifer; P Lei; M J Petris; S T Andreadis; O J Baker
Journal:  J Dent Res       Date:  2020-10-10       Impact factor: 6.116

3.  Stimulated saliva composition in patients with cancer of the head and neck region.

Authors:  Ulrica Almhöjd; Hulya Cevik-Aras; Niclas Karlsson; Jin Chuncheng; Annica Almståhl
Journal:  BMC Oral Health       Date:  2021-10-09       Impact factor: 2.757

4.  Regulation of Quality of Life and Immune Function in Patients with Thyroid Cancer Treated by Deep Learning Technology.

Authors:  Xiandong Fu; Xinxin Yang; Yibo Wang; Nannan Chi; Jianan Yu; Yao Feng
Journal:  Contrast Media Mol Imaging       Date:  2022-08-30       Impact factor: 3.009

5.  Variations in odontological care routines for patients undergoing treatment for head and neck cancer in county councils/regions of Sweden.

Authors:  Niklas Bohm; Charlott Karlsson; Jessica Skoogh Andersson; Annica Almståhl
Journal:  Clin Exp Dent Res       Date:  2019-09-19

6.  Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study.

Authors:  Anna Vesty; Kim Gear; Sharon Boutell; Michael W Taylor; Richard G Douglas; Kristi Biswas
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

7.  Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.

Authors:  Puja Aggarwal; Katherine A Hutcheson; Adam S Garden; Frank E Mott; Charles Lu; Ryan P Goepfert; Clifton D Fuller; Stephen Y Lai; G Brandon Gunn; Mark S Chambers; Erich M Sturgis; Ehab Y Hanna; Sanjay Shete
Journal:  Cancer       Date:  2021-08-06       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.